BlackRock Fund Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
CBOA
VAM
BG
BlackRock Fund Advisors's RDY Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 1.2% in Q4 2016, buying an estimated $83.9K and bringing the position to 750,035 shares worth $6.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2783.
BlackRock Fund Advisors first reported a position in RDY in Q2 2013 and has held it in 15 quarters since. The position peaked at $11.1M in Q3 2015. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.
- BlackRock Fund Advisors held 750,035 shares of Dr. Reddy's Laboratories worth $6.79M as of Q4 2016.
- BlackRock Fund Advisors bought 9,020 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $83.9K.
- Dr. Reddy's Laboratories made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2783 holding.
- BlackRock Fund Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 15 quarters since.
- BlackRock Fund Advisors's Dr. Reddy's Laboratories position peaked at $11.1M in Q3 2015.
- 164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.